| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |